Study Finds Adult Vaccination Programs Deliver 19x Returns 18/04/2024 Maayan Hoffman Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs. Beyond saving lives and preventing severe illnesses, the study found these programs offer substantial financial advantages to nations by reducing the need for costly hospitalizations and emergency medical interventions and avoiding […] Continue reading -> Moderna’s ‘Disappointing’ Pull Back from Kenya Highlights Complexity of Expanding Vaccine Manufacturing in Africa 16/04/2024 Kerry Cullinan “Disappointed” is how the Africa Centres for Disease Control and Prevention phrased its response to pharmaceutical company Moderna “pausing” its Kenyan mRNA vaccine manufacturing facility. Moderna’s decision is yet another example of how complex it is to kickstart vaccine manufacturing on the continent – an essential component to safeguard Africans against future pandemics on the […] Continue reading -> Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues New Guidance for Reducing Avoidable Harm from Medicines 14/03/2024 Zuzanna Stawiska As many as one in 20 patients experience avoidable side effects from medication that they use, with this figure rising to 7% in developing countries. The causes range from taking the medication at the wrong time, which could result in minor side effects, to taking an inappropriate drug, which might result in unpredicted harm as […] Continue reading -> New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna’s ‘Disappointing’ Pull Back from Kenya Highlights Complexity of Expanding Vaccine Manufacturing in Africa 16/04/2024 Kerry Cullinan “Disappointed” is how the Africa Centres for Disease Control and Prevention phrased its response to pharmaceutical company Moderna “pausing” its Kenyan mRNA vaccine manufacturing facility. Moderna’s decision is yet another example of how complex it is to kickstart vaccine manufacturing on the continent – an essential component to safeguard Africans against future pandemics on the […] Continue reading -> Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues New Guidance for Reducing Avoidable Harm from Medicines 14/03/2024 Zuzanna Stawiska As many as one in 20 patients experience avoidable side effects from medication that they use, with this figure rising to 7% in developing countries. The causes range from taking the medication at the wrong time, which could result in minor side effects, to taking an inappropriate drug, which might result in unpredicted harm as […] Continue reading -> New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine 15/04/2024 Zuzanna Stawiska Nigeria has incorporated a cutting-edge meningitis vaccine into its immunization programmes, becoming the first country on the continent to roll it out. The vaccine provides immunity against as many as five strains of deadly meningococcus bacteria, WHO announced on Friday. “Meningitis is an old and deadly foe, but this new vaccine holds the potential to […] Continue reading -> New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues New Guidance for Reducing Avoidable Harm from Medicines 14/03/2024 Zuzanna Stawiska As many as one in 20 patients experience avoidable side effects from medication that they use, with this figure rising to 7% in developing countries. The causes range from taking the medication at the wrong time, which could result in minor side effects, to taking an inappropriate drug, which might result in unpredicted harm as […] Continue reading -> New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise 10/04/2024 Sophia Samantaroy As global cases of dengue are already close to last year’s record high of over four million, the Americas region is struggling to contain high transmission levels. Unplanned urbanization, heavier rainfall, warmer temperatures, and the El Nino effect create perfect conditions for the Aedes aegypti mosquito, the primary vector of dengue. The Southern Cone region […] Continue reading -> Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues New Guidance for Reducing Avoidable Harm from Medicines 14/03/2024 Zuzanna Stawiska As many as one in 20 patients experience avoidable side effects from medication that they use, with this figure rising to 7% in developing countries. The causes range from taking the medication at the wrong time, which could result in minor side effects, to taking an inappropriate drug, which might result in unpredicted harm as […] Continue reading -> New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Amid Global Cholera Surge, Gavi Launches New Testing Programme 10/04/2024 Zuzanna Stawiska A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries. “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading -> WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues New Guidance for Reducing Avoidable Harm from Medicines 14/03/2024 Zuzanna Stawiska As many as one in 20 patients experience avoidable side effects from medication that they use, with this figure rising to 7% in developing countries. The causes range from taking the medication at the wrong time, which could result in minor side effects, to taking an inappropriate drug, which might result in unpredicted harm as […] Continue reading -> New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues New Guidance for Reducing Avoidable Harm from Medicines 14/03/2024 Zuzanna Stawiska As many as one in 20 patients experience avoidable side effects from medication that they use, with this figure rising to 7% in developing countries. The causes range from taking the medication at the wrong time, which could result in minor side effects, to taking an inappropriate drug, which might result in unpredicted harm as […] Continue reading -> New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Indian Pharma Companies Under Investigation For Poor Drug Quality Donate Millions to Political Parties 19/03/2024 Editorial team Seven Indian pharmaceutical companies made donations to domestic political parties while they were under investigation for substandard drug production, according to an investigation published in Scroll. The companies named in the investigation included Hetero Labs and Hetero Healthcare, Torrent Pharma, Zydus Healthcare, Glenmark, Cipla, IPCA Laboratories Limited, and Intas Pharmaceutical. They were under investigation for […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues New Guidance for Reducing Avoidable Harm from Medicines 14/03/2024 Zuzanna Stawiska As many as one in 20 patients experience avoidable side effects from medication that they use, with this figure rising to 7% in developing countries. The causes range from taking the medication at the wrong time, which could result in minor side effects, to taking an inappropriate drug, which might result in unpredicted harm as […] Continue reading -> New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> WHO Issues New Guidance for Reducing Avoidable Harm from Medicines 14/03/2024 Zuzanna Stawiska As many as one in 20 patients experience avoidable side effects from medication that they use, with this figure rising to 7% in developing countries. The causes range from taking the medication at the wrong time, which could result in minor side effects, to taking an inappropriate drug, which might result in unpredicted harm as […] Continue reading -> New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Issues New Guidance for Reducing Avoidable Harm from Medicines 14/03/2024 Zuzanna Stawiska As many as one in 20 patients experience avoidable side effects from medication that they use, with this figure rising to 7% in developing countries. The causes range from taking the medication at the wrong time, which could result in minor side effects, to taking an inappropriate drug, which might result in unpredicted harm as […] Continue reading -> New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Declaration by African Ministers to Advance Malaria Elimination Receives Mixed Reception 07/03/2024 Elaine Ruth Fletcher A new declaration by health ministers from African countries that have the highest malaria burden has reaffirmed the “unwavering commitment to the accelerated reduction of malaria mortality”. The declaration, issued Wednesday by ministers convening in Yaoundé, Cameroon at an African-wide WHO conference on malaria, aims to revitalise the campaign to drive deaths from malaria further […] Continue reading -> Posts navigation Older posts